Education
About Us
Working with TipRanks
Follow Us
Edgewell Personal Care (EPC)
NYSE:EPC
Top Page
Edgewell Personal Care
(NYSE:EPC)
65Neutral
Positive Factors
Market Share and Category Trends
Category trends and Edgewell's market shares in North America improved as it exited the quarter.
Strategic Reinvestment
The company is stepping up its reinvestment spend next quarter to support promising campaigns in US Women's Shave and Sun.
Negative Factors
North America Performance
A large and disconcerting 6% North America decline, with some outsized temporary pressures, including supply issues and a weaker than expected end to sun care season on weather.
Sales and Earnings Guidance
Edgewell's organic sales growth fell short of its own and Street estimates this quarter and the company cut its sales and earnings guidance for the full year.
Tariff and Cost Pressures
Management lowered guidance and earnings expectations for the year on the weaker 2Q results and lowered earnings expectations due to incremental tariff pressures, increased promo investment needed, and higher A&P expectations.
Edgewell Personal Care (EPC) vs. S&P 500 (SPY)
Market Cap
$1.45B
Dividend Yield2.22%
Average Volume (3M)449.64K
Price to Earnings (P/E)16.8
Beta (1Y)0.60
Revenue Growth-2.11%
EPS Growth-28.79%
CountryUS
Employees6,700
SectorConsumer Defensive
Sector Strength82
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)0.87
Shares Outstanding48,228,670
10 Day Avg. Volume375,669
30 Day Avg. Volume449,639
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap2.02
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit3.06
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$30.83Price Target Upside13.97% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
Edgewell Personal Care Business Overview & Revenue Model
Company DescriptionEdgewell Personal Care (EPC) is a leading consumer products company that specializes in personal care products. The company operates in various sectors, including grooming, sun and skin care, and feminine care. Core products include well-known brands such as Schick and Wilkinson Sword for shaving, Banana Boat and Hawaiian Tropic for sun protection, and Playtex and Stayfree for feminine care.
How the Company Makes MoneyEdgewell Personal Care generates revenue primarily through the sale of its consumer products across various categories. The company leverages a diverse portfolio of well-established brands in grooming, sun and skin care, and feminine care to reach a wide consumer base. Key revenue streams include direct sales to major retailers, both brick-and-mortar and online, and distribution partnerships. The company also engages in strategic marketing and brand positioning to maintain its market share and drive consumer demand. Additionally, Edgewell may explore licensing agreements and product innovations as part of its growth strategy.
Edgewell Personal Care Financial Statement Overview
Summary
Overall, Edgewell Personal Care demonstrates stable financial performance with consistent revenue and cash flow generation. The company maintains a reasonable balance between debt and equity, although there are areas for improvement in profit margins and equity growth. Continued focus on cost management and capital efficiency will be key to enhancing financial health.Income Statement
The income statement shows a moderate performance with a consistent revenue base. The TTM gross profit margin is approximately 42.3%, indicating decent cost management. However, the net profit margin of around 4.1% suggests room for improvement in efficiency. Revenue growth has been stable, with a slight dip in the most recent TTM compared to the previous annual period.―
Balance Sheet
The balance sheet reflects a stable financial structure with a debt-to-equity ratio of 0.98, which is manageable but suggests reliance on debt. The equity ratio stands at approximately 40.5%, indicating a balanced capital structure. However, there has been a slight decline in stockholders' equity over the last year, which could be a concern if the trend continues.65
Cash Flow
Cash flow analysis reveals strong operating cash flow with a TTM figure of $188.3 million, supporting a healthy operating cash flow to net income ratio of 2.05. Free cash flow growth is positive, indicating solid cash generation. However, fluctuations in capital expenditure and financing activities could introduce some volatility.―
| Breakdown | ||||
| Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 |
|---|---|---|---|---|
| Income Statement | Total Revenue | |||
| 2.25B | 2.25B | 2.17B | 2.09B | 1.95B | Gross Profit |
| 955.70M | 938.40M | 879.40M | 950.10M | 880.90M | EBIT |
| 199.30M | 224.60M | 181.20M | 238.80M | 195.20M | EBITDA |
| 285.50M | 317.60M | 285.40M | 301.00M | 237.30M | Net Income Common Stockholders |
| 98.60M | 114.70M | 99.50M | 117.80M | 67.60M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
| 209.10M | 216.40M | 188.70M | 479.20M | 364.70M | Total Assets |
| 3.73B | 3.74B | 3.71B | 3.67B | 3.54B | Total Debt |
| 1.30B | 1.45B | 1.41B | 1.26B | 1.26B | Net Debt |
| 1.09B | 1.23B | 1.22B | 781.50M | 894.30M | Total Liabilities |
| 2.15B | 2.20B | 2.25B | 2.09B | 2.11B | Stockholders Equity |
| 1.58B | 1.54B | 1.46B | 1.58B | 1.43B |
| Cash Flow | Free Cash Flow | |||
| 174.50M | 166.60M | 45.60M | 172.20M | 184.90M | Operating Cash Flow |
| 231.00M | 216.10M | 102.00M | 229.00M | 232.60M | Investing Cash Flow |
| -62.40M | -50.50M | -355.40M | -48.70M | -196.40M | Financing Cash Flow |
| -179.40M | -146.50M | -17.60M | -65.40M | -18.70M |
Edgewell Personal Care Technical Analysis
Negative
27.05
Price Trends
30.20
Negative
31.31
Negative
33.89
Negative
Market Momentum
-0.39
Positive
31.71
Neutral
33.37
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For EPC, the sentiment is Negative. The current price of 27.05 is below the 20-day moving average (MA) of 29.91, below the 50-day MA of 30.20, and below the 200-day MA of 33.89, indicating a bearish trend. The MACD of -0.39 indicates Positive momentum. The RSI at 31.71 is Neutral, neither overbought nor oversold. The STOCH value of 33.37 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for EPC.
Edgewell Personal Care Risk Analysis
Edgewell Personal Care disclosed 23 risk factors in its most recent earnings report. Edgewell Personal Care reported the most risks in the “Production” category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Edgewell Personal Care Peers Comparison
Overall Rating
UnderperformOutperform
Sector (64)
Financial Indicators
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $3.85B | 21.45 | 22.16% | 2.54% | 10.32% | 18.55% | |
69 Neutral | $1.66B | 15.96 | 2.79% | 2.78% | 1.46% | -95.70% | |
65 Neutral | $1.45B | 16.76 | 5.53% | 2.22% | -2.11% | -28.79% | |
64 Neutral | $8.81B | 14.72 | 5.05% | 174.27% | 3.55% | 3.81% | |
63 Neutral | $582.97M | 4.71 | 7.45% | ― | -4.93% | -23.61% | |
58 Neutral | $285.59M | ― | -4.93% | 3.90% | -11.85% | -1080.00% | |
49 Neutral | $2.08B | ― | -8.46% | 5.32% | -6.09% | 17.71% |
* Consumer Defensive Sector Average
Performance Comparison
EPC
Edgewell Personal Care
27.05
-12.26
-31.19%
HELE
Helen Of Troy
27.28
-75.12
-73.36%
IPAR
Inter Parfums
118.97
-0.03
-0.03%
NWL
Newell Brands
5.22
-2.57
-32.99%
NUS
Nu Skin
6.84
-6.03
-46.85%
SPB
Spectrum Brands Holdings
61.86
-31.04
-33.41%
Edgewell Personal Care Earnings Call Summary
Earnings Call Date:May 07, 2025
(Q2-2025)
| % Change Since: -9.89%|
Next Earnings Date:Aug 12, 2025
Earnings Call Sentiment Neutral
The earnings call highlighted significant international growth and strong brand performance in specific areas like the Billie brand. However, this was offset by challenges in North America, including declines in Sun Care and Fem Care sales, and the impact of tariffs on costs. The outlook for the second half of the fiscal year is cautious due to expected lower consumption trends.Q2-2025 Updates
Positive Updates
Record International Growth
International markets saw 3% organic growth, marking the 12th growth quarter in the last 13. This growth was driven by both price and volume gains.
Productivity Savings
Edgewell realized approximately 380 basis points of productivity savings, which contributed to a 110 basis points constant currency gross margin accretion.
Strong Brand Performance
The Billie brand saw significant market share gains, reaching a 15% share at Walmart and 14% at Target in women's systems.
Successful International Innovations
Notable product launches in international markets included the expansion of the Billie brand to Australia and new product innovations in Japan.
Negative Updates
Decline in North America Sales
Organic sales in North America declined about 4%, driven by declines in Sun, Shave Preps, and Fem Care.
Tariff-Related Cost Impact
The in-year cost impact of tariffs is estimated to be $3 million to $4 million, with an annualized exposure of 3% to 4% of COGS.
Lower U.S. Sun Care Sales
Sun Care sales in the U.S. declined due to poor weather and order phasing related to the Easter holiday.
Fem Care Portfolio Struggles
Fem Care organic sales declined 9%, with the category showing slow recovery and consumption declines in tampons and pads.
Company Guidance
During Edgewell's Second Quarter Fiscal Year 2025 Earnings Call, the company provided guidance reflecting a cautious outlook due to a challenging macroeconomic environment. They revised their full-year organic net sales growth expectation to a range of flat to 1%, with a forecast of 2% growth in the second half. The company anticipates full-year adjusted earnings per share to be between $2.85 and $3.05, impacted by approximately $0.35 per share in currency headwinds. Adjusted EBITDA is expected to be in the range of $329 million to $341 million, also inclusive of currency impacts. Tariffs are anticipated to have a $3 million to $4 million impact on COGS for fiscal 2025, with an annualized exposure of 3% to 4% of COGS. Despite these challenges, Edgewell is incrementally investing in North America, particularly in Sun Care and Women's Shave, to strengthen market position and anticipates sequential improvement in the region's performance.Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.